A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP1(19)

The most widespread Plasmodium species, Plasmodium vivax, poses a significant public health threat. An effective vaccine is needed to reduce global malaria burden. Of the erythrocytic stage vaccine candidates, the 19 kDa fragment of the P. vivax Merozoite Surface Protein 1 (PvMSP1(19)) is one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fonseca, Jairo Andres, Cabrera-Mora, Monica, Singh, Balwan, Oliveira-Ferreira, Joseli, da Costa Lima-Junior, Josué, Calvo-Calle, J. Mauricio, Lozano, Jose Manuel, Moreno, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052570/
https://www.ncbi.nlm.nih.gov/pubmed/27708348
http://dx.doi.org/10.1038/srep34527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052570/
https://www.ncbi.nlm.nih.gov/pubmed/27708348
http://dx.doi.org/10.1038/srep34527

Ejemplares similares